Sanhita Sinharay1, Dima A Hammoud2. 1. Center for Infectious Disease Imaging, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health (NIH), 10 Center Drive, Room 1C368, Bethesda, MD, 20892, USA. 2. Center for Infectious Disease Imaging, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health (NIH), 10 Center Drive, Room 1C368, Bethesda, MD, 20892, USA. hammoudd@cc.nih.gov.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to summarize recent developments in PET imaging of neuropathologies underlying HIV-associated neurocognitive dysfunction (HAND). We concentrate on the recent post antiretroviral era (ART), highlighting clinical and preclinical brain PET imaging studies. RECENT FINDINGS: In the post ART era, PET imaging has been used to better understand perturbations of glucose metabolism, neuroinflammation, the function of neurotransmitter systems, and amyloid/tau protein deposition in the brains of HIV-infected patients and HIV animal models. Preclinical and translational findings from those studies shed a new light on the complex pathophysiology underlying HAND. The molecular imaging capabilities of PET in neuro-HIV are great complements for structural imaging modalities. Recent and future PET imaging studies can improve our understanding of neuro-HIV and provide biomarkers of disease progress that could be used as surrogate endpoints in the evaluation of the effectiveness of potential neuroprotective therapies.
PURPOSE OF REVIEW: The purpose of this review is to summarize recent developments in PET imaging of neuropathologies underlying HIV-associated neurocognitive dysfunction (HAND). We concentrate on the recent post antiretroviral era (ART), highlighting clinical and preclinical brain PET imaging studies. RECENT FINDINGS: In the post ART era, PET imaging has been used to better understand perturbations of glucose metabolism, neuroinflammation, the function of neurotransmitter systems, and amyloid/tau protein deposition in the brains of HIV-infectedpatients and HIV animal models. Preclinical and translational findings from those studies shed a new light on the complex pathophysiology underlying HAND. The molecular imaging capabilities of PET in neuro-HIV are great complements for structural imaging modalities. Recent and future PET imaging studies can improve our understanding of neuro-HIV and provide biomarkers of disease progress that could be used as surrogate endpoints in the evaluation of the effectiveness of potential neuroprotective therapies.
Authors: Philip J Santangelo; Kenneth A Rogers; Chiara Zurla; Emmeline L Blanchard; Sanjeev Gumber; Karen Strait; Fawn Connor-Stroud; David M Schuster; Praveen K Amancha; Jung Joo Hong; Siddappa N Byrareddy; James A Hoxie; Brani Vidakovic; Aftab A Ansari; Eric Hunter; Francois Villinger Journal: Nat Methods Date: 2015-03-09 Impact factor: 28.547
Authors: S F An; B Giometto; M Groves; R F Miller; A A Beckett; F Gray; B Tavolato; F Scaravilli Journal: J Neuropathol Exp Neurol Date: 1997-11 Impact factor: 3.685
Authors: Beau M Ances; Tammie L Benzinger; Jon J Christensen; Jewell Thomas; Rohit Venkat; Mengesha Teshome; Patricia Aldea; Anne M Fagan; David M Holtzman; John C Morris; David B Clifford Journal: Arch Neurol Date: 2012-01
Authors: Sarah E Beck; Kathleen M Kelly; Suzanne E Queen; Robert J Adams; M Christine Zink; Patrick M Tarwater; Joseph L Mankowski Journal: J Neurovirol Date: 2015-02-12 Impact factor: 2.643
Authors: F Steinbrink; S Evers; B Buerke; P Young; G Arendt; E Koutsilieri; D Reichelt; H Lohmann; I-W Husstedt Journal: Eur J Neurol Date: 2012-10-25 Impact factor: 6.089
Authors: Patrick W Wright; Florin F Vaida; Ricardo J Fernández-de Thomas; Jerrel Rutlin; Richard W Price; Evelyn Lee; Julia Peterson; Dietmar Fuchs; Joshua S Shimony; Kevin R Robertson; Rudolph Walter; Dieter J Meyerhoff; Serena Spudich; Beau M Ances Journal: AIDS Date: 2015-02-20 Impact factor: 4.632
Authors: Margaret R Lentz; Kristin L Peterson; Wael G Ibrahim; Dianne E Lee; Joelle Sarlls; Martin J Lizak; Dragan Maric; William C Reid; Dima A Hammoud Journal: PLoS One Date: 2014-08-21 Impact factor: 3.240
Authors: Michael D Boska; Prasanta K Dash; Jaclyn Knibbe; Adrian A Epstein; Sidra P Akhter; Natasha Fields; Robin High; Edward Makarov; Stephen Bonasera; Harris A Gelbard; Larisa Y Poluektova; Howard E Gendelman; Santhi Gorantla Journal: Mol Neurodegener Date: 2014-12-18 Impact factor: 14.195
Authors: Zeping Wang; Maura M Manion; Elizabeth Laidlaw; Adam Rupert; Chuen-Yen Lau; Bryan R Smith; Avindra Nath; Irini Sereti; Dima A Hammoud Journal: AIDS Date: 2021-07-01 Impact factor: 4.632
Authors: Clementine Wallet; Marco De Rovere; Jeanne Van Assche; Fadoua Daouad; Stéphane De Wit; Virginie Gautier; Patrick W G Mallon; Alessandro Marcello; Carine Van Lint; Olivier Rohr; Christian Schwartz Journal: Front Cell Infect Microbiol Date: 2019-10-24 Impact factor: 5.293
Authors: Chuen-Yen Lau; Matthew A Adan; Jessica Earhart; Cassie Seamon; Thuy Nguyen; Ariana Savramis; Lindsey Adams; Mary-Elizabeth Zipparo; Erin Madeen; Kristi Huik; Zehava Grossman; Benjamin Chimukangara; Wahyu Nawang Wulan; Corina Millo; Avindra Nath; Bryan R Smith; Ana M Ortega-Villa; Michael Proschan; Bradford J Wood; Dima A Hammoud; Frank Maldarelli Journal: Front Med (Lausanne) Date: 2022-08-22